January 17, 2025 Maria Dranishnikova Outsmarting cancer: Why immune-oncology firm MAIA has 600% upside
January 16, 2025 Maria Dranishnikova Cancer therapy and vaccine maker GeoVax gains on progress in cancer drug trials
December 17, 2024 Maria Dranishnikova MAIA soars after its cancer drug receives FDA ‘rare pediatric disease’ designation